Peter Attia· MD
both of them the design aim to collect a substantial number of participants and try to see how many of them had antibodies to the virus which means that they had been infected perhaps at least a couple weeks ago
Loading…
The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
both of them the design aim to collect a substantial number of participants and try to see how many of them had antibodies to the virus which means that they had been infected perhaps at least a couple weeks ago
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.